Skip to main content
. 2017 Feb 17;50(4):1116–1126. doi: 10.3892/ijo.2017.3880

Figure 5.

Figure 5

Treatment with Lenti-si-UBE2C suppresses gastric cancer growth in vivo. (A and B) Mouse and tumor samples from the MGC-803/Control and MGC-803/Lenti-si-AURKA groups. (C–E) The mouse body weights, tumor growth and weight were evaluated using the in vivo proliferation assay, repectively. UBE2C, ubiquitin-conjugating enzyme 2C; AURKA, Aurora-A.